Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 749


Results: 6
    1

    An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 749, p. 1, doi. 10.1126/scitranslmed.abp8334
    By:
    • Davis, Alison J.;
    • Brooijmans, Natasja;
    • Brubaker, Jason D.;
    • Stevison, Faith;
    • LaBranche, Timothy P.;
    • Albayya, Faris;
    • Fleming, Paul;
    • Hodous, Brian L.;
    • Kim, Joseph L.;
    • Kim, Sean;
    • Lobbardi, Riadh;
    • Palmer, Michael;
    • Sheets, Michael P.;
    • Vassiliadis, John;
    • Wang, Ruduan;
    • Williams, Brett D.;
    • Wilson, Douglas;
    • Xu, Lan;
    • Zhu, Xing Julia;
    • Bouchard, Keith
    Publication type:
    Article
    2
    3

    Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 749, p. 1, doi. 10.1126/scitranslmed.adg9814
    By:
    • Fowler, Daniel;
    • Barisa, Marta;
    • Southern, Alba;
    • Nattress, Callum;
    • Hawkins, Elizabeth;
    • Vassalou, Eleni;
    • Kanouta, Angeliki;
    • Counsell, John;
    • Rota, Enrique;
    • Vlckova, Petra;
    • Draper, Benjamin;
    • De Mooij, Tessa;
    • Farkas, Andrea;
    • Brezovjakova, Helena;
    • Baker, Alfie T.;
    • Scotlandi, Katia;
    • Manara, Maria C.;
    • Tape, Chris;
    • Chester, Kerry;
    • Anderson, John
    Publication type:
    Article
    4
    6